Eskayef Pharmaceuticals Ltd. is one of the leaders in Bangladesh’s pharmaceutical industry. With its presence across the world, it has earned coveted accreditations from the US FDA, UK MHRA, EU EMA, TGA Australia, and more. Eskayef spread its wings in 1990 when the Bangladeshi operations of SmithKline & French were acquired by Transcom Group.
Eskayef prides itself on being a trusted manufacturer of top-quality medicine for Bangladesh and the world.
Multinational SmithKline & French (SK&F) enters Bangladesh
Transcom acquires SmithKline & French (SK&F) and becomes Eskayef Bangladesh Ltd
Eskayef Bangladesh Ltd. emerges as Eskayef Pharmaceuticals Ltd. to go more global
Pioneering of Pellet Technology in Bangladesh
Beginning of International Business
Accreditation by TGA Australia
Commissioning of Rupgonj Plant
The Faraaz Ayaaz Hossain Building manufacturing facility receives the prestigious US FDA approval.
YEAR: 2022
YEAR: 2008, 2011, 2014, 2017
YEAR: 2011, 2014, 2017
Faraaz Ayaaz Hossain Building Tablet, Capsule & Pellets (2017) & Eskayef Oncology Sterile injection & Oral Solid (2020)
YEAR: 2010, 2012, 2015
Eskayef Oncology Sterile injection (2021)
Eskayef Pharmaceuticals Limited is recognized as a model of trust and efficiency by blue chip multinationals.
Eskayef has been manufacturing insulin for Novo Nordisk, from its state-of-the-art & dedicated insulin manufacturing facility since 2012.In January 2018, Eskayef signed a historic agreement with Novo Nordisk to become its first-ever partner to contract manufacture its cutting-edge modern penfill insulin.In 2022, Eskayef inaugurated its state-of-the-art facility to manufacture modern penfill insulin for Novo Nordisk.
Eskayef is manufacturing products for Servier, France since 2009.
Managing Director & CEO
Executive Director - Marketing and Sales
Executive Director - Technical Services
Executive Director - Quality Assurance
Executive Director - Commercial & HR
Executive Director - Finance
Executive Director - Plant
Executive Director - Plant